Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Endocrinology & Diabetes ResearchISSN: 2470-7570
Joan Auwerx Author
Subjects of specialization
Affiliation
working in The Journal of Cell Biology
I graduated with MD and PhD degrees from the Katholieke Universiteit Leuven in Belgium. I performed post-doctoral work
Biography
Swiss Federal Institute of Technology in Zurich, University of Lausanne at the University of Washington, Seattle, where I worked in the Division of Medical Genetics with Samir Deeb and the Division of Endocrinology and Metabolism with John Brunzell and Alan Chait.
Publications
Rapid Communication Subscription
The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome
Author(s): Tatsuya Suzuki, Masao Hashimoto, Shoko Futami-Suda, Yoshimasa Igari, Kentaro Watanabe, Hiroshi Nakano, Joan Auwerx, Mitsuhiro Watanabe and Kenzo Oba
The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome
Bile acid–binding resins (BABRs) improve hyperglycemia in patients with type 2 diabetes, and the BABR colesevelam has been approved by the U.S. Food and Drug Administration for use as an antihyperglycemic agent. Colestimide (colestilan) is a new type of anion resin that increases the number of hepatic low-density lipoprotein receptors and decreases serum cholesterol levels by promoting the excretion of bile acids and inhibiting the absorption of cholesterol in the intestine; with these changes, the serum level of low-density lipoprotein cholesterol decreases.
... view more»Social Media
Google Scholars / Researchers Sites
